Exploring the cellular neighborhood
Software allows scientists to model shapeshifting proteins in native cellular environments.
Software allows scientists to model shapeshifting proteins in native cellular environments.
Study finds stimulating a key brain rhythm with light and sound increases peptide release from interneurons, driving clearance of an Alzheimer’s protein.
Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.
A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.
Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.
Biologists demonstrate that HIV-1 capsid acts like a Trojan horse to pass viral cargo across the nuclear pore.
MIT study suggests 3D folding of the genome is key to cells’ ability to store and pass on “memories” of which genes they should express.
The vibrating platform could be useful for growing artificial muscles to power soft robots and testing therapies for neuromuscular diseases.
By focusing on causal relationships in genome regulation, a new AI method could help scientists identify new immunotherapy techniques or regenerative therapies.
New professor of biology uses budding yeast to address fundamental questions in cell biology.
Researchers compared a pair of superficially similar motor neurons in fruit flies to examine how their differing use of the same genome produced distinctions in form and function.
A new study bridging neuroscience and machine learning offers insights into the potential role of astrocytes in the human brain.
A single protein can self-assemble to build the scaffold for a biomolecular condensate that makes up a key nucleolar compartment.
MIT PhD student Kathrin Kajderowicz is studying how hibernation-like states could pave the way for new hypothermic therapies.
SMART researchers find the enzyme RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.